This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Judy M. Obliosca: Innovator in Epigenetic Detection
Introduction
Judy M. Obliosca is a prominent inventor based in Austin, TX. She has made significant contributions to the field of epigenetics through her innovative research and patented technologies. Her work focuses on the detection and quantification of epigenetic modifications in DNA, which has important implications for understanding genetic regulation and disease.
Latest Patents
Judy holds a patent for "Metal nanocluster beacons for detection of epigenetic modifications." This invention provides compositions and methods for detecting and quantifying epigenetic modifications in DNA. The patent describes probes that utilize fluorescent metal nanocluster beacons, which can selectively detect nucleic acids that include epigenetic modifications. This technology represents a significant advancement in the field of genetic research.
Career Highlights
Judy M. Obliosca is affiliated with The University of Texas System, where she conducts her research and develops her innovative technologies. Her work has garnered attention for its potential applications in medical diagnostics and therapeutic development.
Collaborations
Judy has collaborated with notable researchers, including Hsin-Chih Yeh and Yu-An Chen, to further advance her work in epigenetics. These collaborations have enriched her research and contributed to the development of her patented technologies.
Conclusion
Judy M. Obliosca is a trailblazer in the field of epigenetic detection, with her patented technology paving the way for future advancements in genetic research. Her contributions are vital for the ongoing exploration of genetic modifications and their implications in health and disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
